Startups
Zendal is a business group of 7 companies focused on Biotechnology and it is engaged in the development, manufacturing and marketing of Biological and Pharmaceutical products for both human and animal health. Biotechnology is crucial tool for disease prevention of human and animaand has the potential to contribute to a healthier planet. Zendal, the corporate brand of our group, draws together seven companies focused on high added value products in the health sector: CZ Vaccines, Biofabri, Vetia, Petia vet health, Zinereo Pharma, Probisearch and Bialactis
Overview
Location
Spain, Galicia, O Porriño
Employees
501-1000
Founded date
1993
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 9, 2023 | Bio & Tech Smart Capital duplica su capacidad de inversión tras recibir la homologación del CDTI como coinversor | 09/06/2023 Nota de prensa BIO & TECH SMART CAPITAL DUPLICA SU CAPACIDAD DE INVERSIÓN TRAS RECIBIR LA HOMOLOGACIÓN DEL CDTI COMO COINVERSOR Bio & Tech Smart Capital, fondo de capital riesgo (venture capital) promovido por el Grupo... |
| Mar 4, 2022 | Noso Capital crea el fondo Bio&Tech Smart Capital, que aspira a gestionar hasta €50 millones | 04/03/2022 Nota de prensa NOSO CAPITAL CREA EL FONDO BIO&TECH SMART CAPITAL, QUE ASPIRA A GESTIONAR HASTA €50 MILLONES. Noso Capital SGEIC, S.A. aprobó la constitución del fondo de capital privado Bio&Tech Smart Capital para impu... |
Reviews 0
FAQ about ZENDAL
When was ZENDAL founded?
ZENDAL was founded in 1993.
What has the press written about ZENDAL?
Parsers VC has collected 3 articles mentioning ZENDAL, among them “Bio & Tech Smart Capital duplica su capacidad de inversión tras recibir la homologación del CDTI como coinversor” (Jun 9, 2023) and “Noso Capital crea el fondo Bio&Tech Smart Capital, que aspira a gestionar hasta €50 millones” (Mar 4, 2022).
Is ZENDAL still active?
Yes, ZENDAL is active; its latest activity on Parsers VC dates from Jul 5, 2023.